Serglycin secreted by leukocytes is efficiently eliminated from the circulation by sinusoidal scavenger endothelial cells in the liver.
This study was undertaken to determine the fate of the circulating chondroitin sulfate proteoglycan serglycin. The human monocytic cell line THP-1 was cultured under serum-free conditions in the presence of [35S]sulfate. The conditioned medium was harvested and 35S-macromolecules were purified by Q-Sepharose anion-exchange chromatography and Superose 6 gel chromatography. After labeling with 125I, the purified material was treated with chondroitinase ABC and subjected to sodium dodecyl sulfate polyacrylamide gel electrophoresis. A major band with mr of approximately 14 kDa appeared, consistent with the core protein of serglycin. The identity of the proteoglycan was confirmed by amino-terminal amino acid sequencing. Purified serglycin, labeled either with [35S]sulfate or 125I and fluorescein isothiocyanate, was injected intravenously into rats. The blood content of radiolabeled serglycin fell by 50% from 1 to 2.4 min after injection, indicating an initial t1/2 of 1.4 min or shorter. Approximately 90% of the recovered radioactivity was localized in the liver, 5% in the blood, and 5% altogether in urine, kidneys, and spleen about 30 min after injection. Isolation of liver cells at the same time point showed that 70% of the radioactivity was taken up by the sinusoidal scavenger endothelial cells, and 23 and 7% by the hepatocytes and Kupffer cells, respectively. When excess amounts of unlabeled hyaluronan was coinjected with radiolabeled serglycin, the elimination of serglycin was significantly inhibited, indicating that the hyaluronan receptor on the sinusoidal scavenger endothelial cells is responsible for the elimination of serglycin.
Oynebråten
I
I
Institute of Medical Biology, University of Tromsø, Norway. inger.oynebraten@labmed.uio.no
Hansen
B
B
Smedsrød
B
B
Uhlin-Hansen
L
L
D000818:Animals; D004705:Endocytosis; D004727:Endothelium / Q000502:physiology; D006801:Humans; D018960:Hyaluronan Receptors / Q000502:physiology; D007728:Kupffer Cells / Q000502:physiology; D007963:Leukocytes, Mononuclear / Q000378:metabolism*; D008099:Liver / Q000166:cytology / Q000502:physiology*; D009363:Neoplasm Proteins / Q000097:blood / Q000378:metabolism / Q000493:pharmacokinetics; D011509:Proteoglycans / Q000097:blood / Q000378:metabolism / Q000493:pharmacokinetics*; D051381:Rats; D014018:Tissue Distribution; D014407:Tumor Cells, Cultured / Q000378:metabolism; D033921:Vesicular Transport Proteins
D018960:Hyaluronan Receptors; D009363:Neoplasm Proteins; D011509:Proteoglycans; D033921:Vesicular Transport Proteins; C075430:serglycin